Ally Bridge Group

New York, United States ยท DeepTech Native
Out of Scope

Bio

Ally Bridge Group Ally Bridge Group was founded in 2013 by Frank Yu, operating from dual offices in New York and Hong Kong. The firm has led or co-led over $6B in transactions across healthcare subsectors, running a dual strategy: private equity (since 2013) and long- biased public equity (since 2018). The focus is US, European, and Chinese healthcare markets at growth, late-stage, and buyout. positioning Ally Bridge as a bridge between global capital and China healthcare opportunities. The por

Industries

BiotechMedTech

Stages

Series ASeries B+

Geography

USEuropeChina

Notable investments

  • WuXi AppTec
  • Grail
  • Shockwave Medical
  • Innovent Biologics